CapsoVision Inc. (CV), a commercial-stage medical technology company, is scheduled to release fourth-quarter and full-year 2025 financial results on Thursday, March 26, 2026, after the close of the market.
The company develops AI-enabled imaging solutions for gastrointestinal (GI) disease detection and screening. Its flagship wire-free capsule endoscopy platform, CapsoCam Plus, offers 360° panoramic imaging with onboard video storage, enabling comprehensive small bowel visualization and detection of conditions such as obscure GI bleeding and Crohn's disease.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.